Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
952
Frequently Asked Questions
What is Market Cap of Novavax, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Novavax, Inc. market cap is $1.28B.
What is the 52-week high for Novavax, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Novavax, Inc. 52 week high is $15.22 as of September 08, 2025.
What is the 52-week low for Novavax, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Novavax, Inc. 52 week low is $5.01 as of September 08, 2025.
What is Novavax, Inc. stock price today?
Novavax, Inc. stock price today is $7.90.
What was Novavax, Inc. stock price yesterday?
Novavax, Inc. stock price yesterday was $7.79.
What is the PE ratio of Novavax, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Novavax, Inc.’s P/E ratio is 3.50.
What is the Price-to-Book ratio of Novavax, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Novavax, Inc. P/B ratio is 34.0473.
What is the 50-day moving average of Novavax, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Novavax, Inc. 50-day moving average is $7.50.
NVAX Novavax Inc